|
|
||||||||
Universität Würzburg, Lehrstuhl für Biotechnologie, Biozentrum der Universität Würzburg, Am Hubland, D-97074 Würzburg, Germany
Correspondence
Christian Andersen
andersen{at}biozentrum.uni-wuerzburg.de
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Currently, the structures of three channel-tunnels are known (Koronakis et al., 2000
; Akama et al., 2004
; Federici et al., 2005
). The trimeric assembly forms a 140 Å (14 nm) long, cannon-shaped structure. It is anchored in the outer membrane by a
-barrel domain and protrudes into the periplasm via a 100 Å (10 nm) long,
-helical tunnel domain, which assembles with inner-membrane complexes to form a continuous export pathway across the cell envelope. In contrast to the wide-open, extracellular entrance, the periplasmic entrance is almost closed, which explains the very low single-channel conductance of the best-characterized representative TolC of E. coli (Andersen et al., 2002a
). For TolC, the role of individual residues in electrophysiological characteristics and opening of the periplasmic entrance has been determined (Andersen et al., 2002b
, c
). It can be shown that an iris-like outwards movement of the inward-folded tunnel helices is necessary to open the periplasmic entrance, allowing export of substrates (Eswaran et al., 2003
; Andersen et al., 2002b
).
In Haemophilus influenzae, a human pathogen responsible for significant morbidity and mortality in young children (Turk, 1984
; Funkhouser et al., 1991
), a multidrug efflux pump has been identified, whose components are homologues of the E. coli AcrAB/TolC efflux pump (Sanchez et al., 1997
; Trepod & Mott, 2004
). The AcrB-homologous HI0895 is a transporter of the resistance nodulation cell division family, which forms a complex with the AcrA-homologous adaptor or membrane fusion protein HI0894 (Sanchez et al., 1997
). This inner-membrane complex interacts with the TolC-homologous, outer-membrane channel-tunnel HI1462 to assemble a functional multidrug efflux pump (Trepod & Mott, 2004
). Disruption of any of the coding genes causes hypersusceptibility to antibiotic agents (Dean et al., 2005
; Sanchez et al., 1997
; Trepod & Mott, 2004
). It can also be shown that a loss of pump repression by mutation or disruption of the AcrR repressor gene is the origin of increased resistance of several clinical H. influenzae isolates, illustrating the importance of this efflux pump (Dean et al., 2005
).
In this study, we have isolated the TolC-homologous HI1462 and characterized the biophysical properties of this pore-forming protein in lipid bilayer experiments. We present a computer model of the HI1462 channel-tunnel which explains its biophysical characteristics. Furthermore, we tested the ability of HI1462 to substitute the E. coli TolC in the AcrAB/TolC efflux pump and the HlyBD/TolC type I secretion system.
| METHODS |
|---|
|
|
|---|
In the same way, the pAra21 vector was made by substituting the IPTG-inducible T7 promoter region of pET-21a (Novagen) with araBADC. Then, the HI1462 gene, conjoined with the N-terminal His-tag, was cloned from pAraJS.2HI1462 into pAra21 using the primers 5'-GAATTACATATGCGGGCGAAAC-3' and 5'-GATTAATCCAATTTGATGAATTCAAATAATATCCCGCCATTG-3' (with restriction sites for NdeI and EcoRI, respectively). The resulting vector contained the HI1462 gene with an N-terminal His10-tag and a C-terminal His6-tag under the control of an arabinose-inducible promoter.
The mutation of the arginine residue 396 to alanine was performed using the QuikChange Site-Directed Mutagenesis kit (Stratagene) on pAra21HI1462biHis with the mutation primers 5'-GCGTATCCGAATTGGCCGAATGGTTAGTTGC-3' and 5'-GCAACTAACCATTCGGCCAATTCGGATACGC-3', following the standard protocol.
tolC was cloned into pBAD/myc-His C using E. coli chromosomal DNA as template and the oligonucleotides 5'-CCACAAGGAATGCTCATGAAGAAATTGC-3' and 5'-GTCGTCATCAGTTACGGAATTCGTTATGACCG-3' as primers (with restriction sites for PagI and EcoRI, respectively). All constructs were confirmed by DNA sequencing (Seqlab).
Bacterial strains and growth conditions.
The E. coli strains and plasmids used in this study are listed in Table 1
. The tolC knockout in AG100 and DC14 was performed according to the method of Datsenko & Wanner (2000)
. A TolC-KO_up primer (5'-CGCGCTAAATACTGCTTCACCACAAGGAATGCAAATGAAGAAGTGTAGGCTGGAGCTGCTTC-3'), a TolC-KO_down primer (5'-CCGTTACTGGTGTAGTGCGTGCGGATGTTTGCTGAACGACTGCATATGAATATCCTCCTTA-3') (underlined region binds to pKD3) and pKD3 as template were used for PCR to produce a tolC knockout fragment. The loss of tolC was verified by colony PCR using primers that bind up- and downstream of tolC. The resulting strains were denoted AG100TC and DC14TC, respectively.
|
Haemolysis was tested on blood-agar plates consisting of 25 ml LB agar supplemented with 0.75 ml defibrinated horse blood, spotted with 0.2 µl cell suspension (1x109 cells ml1) and incubated for 18 h at 37 °C. MIC tests were performed in 96-well plates by serial dilution of the tested antimicrobial agent in LB medium with 2x104 cells per well as the inoculum. The plates were incubated overnight at 37 °C and analysed photometrically after 24 h with an ELISA reader (Molecular Devices) at 600 nm.
Protein expression.
E. coli BL21(DE3)Omp8 pAra21HI1462biHis was routinely grown at 37 °C with shaking (150 r.p.m.) in LB medium with ampicillin. Expression of HI1462 was induced by adding 0.02 % (w/v) arabinose at OD650 0.50.6. The culture was grown at 30 °C to prevent formation of inclusion bodies. After 3 h, cells were harvested by centrifugation (5000 g for 15 min) and washed twice in 10 mM Tris/HCl (pH 8.0). Cells were passed three times through a French pressure cell at 900 p.s.i. (6210 kPa). Unbroken cells were removed by centrifugation at 5000 g for 15 min. The cell envelope was obtained by centrifugation of the supernatant at 170 000 g for 60 min. The pellet was successively resuspended in 2 ml 1 % (v/v) Triton (twice), 1 % (v/v) lauryldimethylamine oxide (LDAO) and 2 % (v/v) LDAO followed by centrifugation at 170 000 g for 60 min, respectively. The 2 % (v/v) LDAO supernatant contained HI1462. For further purification, the supernatant was separated by FPLC using a MonoQ column (Pharmacia) and 0.5 % (v/v) LDAO 10 mM Tris (pH 8.0) as buffer. For elution of bound proteins, the KCl concentration in the buffer was raised continuously from 0 to 1 M. HI1462 eluted at 200 mM KCl. Finally, HI1462-containing fractions were applied to His-Select Ni-nitrilotriacetic acid (NTA) spin columns (Sigma).
SDS-PAGE and Western blotting.
SDS-PAGE was performed according to the Laemmli gel system (Laemmli, 1970
). The gels were stained with Coomassie brilliant blue or with silver stain (Blum et al., 1987
). Western blots were processed with the Bio-Rad Tank-Blot system with Protran nitrocellulose transfer membranes (Schleicher & Schuell BioScience) by applying a constant current of 350 mA for 30 min. The ECL Western Blotting Detection kit (Amersham Pharmacia Biotech) was used to detect binding of the Anti-His antibody according to the manufacturer's instructions.
Lipid bilayer experiments.
The methods used for the lipid bilayer experiments have been described in detail by Benz et al. (1978)
. Black lipid bilayer membranes were obtained from 1 % (w/v) diphytanoyl phosphatidylcholine (Avanti Polar Lipids) in n-decane. The temperature was maintained at 20 °C during all experiments. Zero-current membrane potentials were measured by establishing a salt gradient across membranes containing 100200 channels, as described by Benz et al. (1985)
.
Protein modelling.
The HI1462 structure was modelled using the Homology module of the InsightII software package (Accelrys) based on the structure of the closest homologous channel-tunnel, OprM of Pseudomonas aeruginosa (Akama et al., 2004
). A refinement of the structure was performed using the CharmM module of the InsightII software package.
| RESULTS |
|---|
|
|
|---|
110 kDa, corresponding to HI1462 trimer. By Western blot analysis, we could clearly confirm that both bands represented HI1462.
|
|
81 pS. Further biophysical characterization of HI1462 channels revealed that the pores were not voltage-dependent in a range between +100 and 100 mV, meaning that the conductance remained unchanged, and no opening or closing was observed. Unlike TolC of E. coli HI1462, channels could not be blocked by the divalent cation Zn2+.
Model of the HI1462 structure explains its biophysical characteristics
The biophysical analysis revealed that HI1462 is anion-specific. This is a major difference to TolC of E. coli, which is highly selective for cations (Andersen et al., 2002a
). To obtain a structural insight at the molecular level, we modelled the structure of HI1462. At present, the structures of three channel-tunnels are known: TolC of E. coli, OprM of P. aeruginosa and VceC of Vibrio cholerae (Koronakis et al., 2000
; Akama et al., 2004
; Federici et al., 2005
). A sequence alignment of the HI1462 sequence showed the best homology with the sequences of OprM (data not shown). Therefore, we used OprM as a template to model the HI1462 structure (Fig. 3a
). Of particular interest are residues at the periplasmic end of the tunnel domain. It is known from E. coli TolC that residues lining the periplasmic entrance have a major effect on the electrophysiological behaviour of the channel-tunnel. Looking at the HI1462 model, there are valine residues (Val400) located on the second helical turn of the most inwardly directed helix, facing the lumen of the periplasmic entrance (Fig. 3b
). These hydrophobic residues might be responsible for the low single-channel conductance observed for HI1462. Below this hydrophobic region, there are three charged residues per monomer, Glu394, Arg396 and Glu397, whereas the arginine residues are nearest to the lumen and are responsible for the electropositive lining of the periplasmic entrance. We suppose that these arginine residues are the origin of the anion-specificity of HI1462.
|
|
280 pS, we also observed a second type of pore for HI1462RA with a single-channel conductance between 1.9 and 2.1 nS in 1 M KCl. The pores were rarely observed and their lifetime was very short. They closed immediately and adopted a conformation with a single-channel conductance of
280 pS corresponding to the small pores (Fig. 4
|
|
|
| DISCUSSION |
|---|
|
|
|---|
It is surprising that OprM of P. aeruginosa, which shows a higher homology to HI1462 than TolC, has a single-channel conductance of 850 pS in 1 M KCl (Wong et al., 2001
), which is almost 20-fold higher than that of HI1462. However, the high single-channel conductance seems to conflict with the solved crystal structure of OprM, which shows a nearly closed periplasmic entrance (Akama et al., 2004
). It should be mentioned that the reconstituted channels are not stable and appear to form substates (Wong et al., 2001
), a characteristic also observed for the open state of TolC (Andersen et al., 2002b
). Additionally, the pore-forming activity of OprM in planar lipid bilayers is very low compared to other reconstituted pore-forming proteins (R. Benz, personal communication), which lets us assume that only a minority of the OprM molecules reconstitute as pores in a transient open state, whereas the majority of the molecules insert into the membrane as closed pores, which allows no passage of ions and cannot therefore be detected by electrophysiological measurements.
The genomic organization of the multidrug efflux pump in H. influenzae resembles that of E. coli to the extent that the gene encoding the channel-tunnel is not linked to those encoding the proteins of the inner-membrane complex. Among the six predicted multidrug efflux pumps in H. influenzae, there is another export mechanism coded by a gene for the membrane fusion protein EmrA (HI0898) and a transporter of the major facilitator superfamily EmrB (HI0897), which also needs a channel-tunnel protein to assemble a functional efflux pump according to the known homologues in E. coli (Lomovskaya & Lewis, 1992
). Therefore, the sole channel-tunnel in H. influenzae HI1462 needs to be compatible with two different inner-membrane complexes. This is in accordance with TolC of E. coli, which is known to interact with at least eight different inner-membrane complexes (Andersen, 2003
). Among these is the HlyBD complex, which with TolC forms a secretion apparatus for haemolysin (Wandersman & Delepelaire, 1990
). Genes encoding a type I secretion system are absent in H. influenzae. Therefore, it is surprising that HI1462 can substitute for TolC in the E. coli protein secretion apparatus. The secretion was not as efficient as that of the wild-type system, which suggests either that the amount of HI1462 is lower compared to TolC, or that the two proteins HlyD and HI1462 are not fully compatible. By higher induction of HI1462, it was possible to increase the amount of secreted haemolysin. However, we never reached the maximal secretion levels observed with cells expressing TolC. Therefore, reduced haemolysin secretion is probably caused by compatibility problems between HlyD and HI1462 in the hybrid system. A slightly bigger halo, observed for the hybrid system including the HI1462RA mutant, might lead to the supposition that facilitated opening of the tunnel entrance by interaction with HlyD plays a role in enhanced secretion. Other hybrid, type I secretion systems have exchanged the outer-membrane component with highly homologous channel-tunnels, e.g. TolC of E. coli, HasF of Serratia marcescens, and PrtF of Erwinia chrysanthemii. They can be interchanged between the different secretion systems without loss of functional secretion (Binet & Wandersman, 1996
; Letoffe et al., 1994
; Akatsuka et al., 1997
). Recently, it has been shown that RaxC, a channel-tunnel of the plant pathogen Xanthomonas oryzae pv. Oryzae, complemented an E. coli tolC mutant in a type I secretion system (da Silva et al., 2004
). However, RaxC is also a channel-tunnel belonging to the protein secretion family. Thus, HI1462 is the first example of a channel-tunnel belonging to the drug efflux family which is able to act as an outer-membrane component for a type I secretion system.
Substitution of TolC by HI1462 as an outer-membrane component of the E. coli AcrAB efflux pump did not restore resistance. Similar results have been observed when trying to complement TolC by OprM of P. aeruginosa (Tikhonova et al., 2002
). It should be mentioned that MIC values are generally much lower for H. influenzae than for E. coli (Trepod & Mott, 2004
). If HI1462 is responsible for the less efficient efflux pump of H. influenzae, the possibility cannot be excluded that the hybrid efflux pump AcrAB/HI1462 in E. coli is functional but does not give rise to the same level of resistance as the wild-type efflux pump. However, there are no reports in the literature which point towards the channel-tunnel as a rate-limiting factor for the efflux. Therefore, we conclude that HI1462 is not compatible with the inner-membrane complex of E. coli. This means that interaction between the inner-membrane complexes of drug efflux pumps and the corresponding channel-tunnels is more specific than the interaction of the inner and outer components of type I secretion systems. Further research is needed to understand these interactions at the molecular level. This is essential for developing drugs that inhibit these export mechanisms and disarm harmful bacteria.
| ACKNOWLEDGEMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Akatsuka, H., Binet, R., Kawai, E., Wandersman, C. & Omori, K. (1997). Lipase secretion by bacterial hybrid ATP-binding cassette exporters: molecular recognition of the LipBCD, PrtDEF, and HasDEF exporters. J Bacteriol 179, 47544760.
Andersen, C. (2003). Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria. Rev Physiol Biochem Pharmacol 147, 122165.[Medline]
Andersen, C., Hughes, C. & Koronakis, V. (2000). Chunnel vision. Export and efflux through bacterial channel-tunnels. EMBO Rep 1, 313318.[CrossRef][Medline]
Andersen, C., Hughes, C. & Koronakis, V. (2002a). Electrophysiological behavior of the TolC channel-tunnel in planar lipid bilayers. J Membr Biol 185, 8392.[CrossRef][Medline]
Andersen, C., Koronakis, E., Bokma, E., Eswaran, J., Humphreys, D., Hughes, C. & Koronakis, V. (2002b). Transition to the open state of the TolC periplasmic tunnel entrance. Proc Natl Acad Sci U S A 99, 1110311108.
Andersen, C., Koronakis, E., Hughes, C. & Koronakis, V. (2002c). An aspartate ring at the TolC tunnel entrance determines ion selectivity and presents a target for blocking by large cations. Mol Microbiol 44, 11311139.[CrossRef][Medline]
Benz, R., Janko, K., Boos, W. & Lauger, P. (1978). Formation of large, ion-permeable membrane channels by the matrix protein (porin) of Escherichia coli. Biochim Biophys Acta 511, 305319.[Medline]
Benz, R., Schmid, A. & Hancock, R. E. (1985). Ion selectivity of gram-negative bacterial porins. J Bacteriol 162, 722727.
Binet, R. & Wandersman, C. (1996). Cloning of the Serratia marcescens hasF gene encoding the Has ABC exporter outer membrane component: a TolC analogue. Mol Microbiol 22, 265273.[CrossRef][Medline]
Blum, H., Beier, H. & Gross, H. J. (1987). Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8, 9399.[CrossRef]
Borges-Walmsley, M. I., McKeegan, K. S. & Walmsley, A. R. (2003). Structure and function of efflux pumps that confer resistance to drugs. Biochem J 376, 313338.[CrossRef][Medline]
da Silva, F. G., Shen, Y., Dardick, C., Burdman, S., Yadav, R. C., de Leon, A. L. & Ronald, P. C. (2004). Bacterial genes involved in type I secretion and sulfation are required to elicit the rice Xa21-mediated innate immune response. Mol Plant Microbe Interact 17, 593601.[Medline]
Datsenko, K. A. & Wanner, B. L. (2000). One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 97, 66406645.
Dean, C. R., Narayan, S., Daigle, D. M. & 8 other authors (2005). Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415. Antimicrob Agents Chemother 49, 31293135.
Delepelaire, P. (2004). Type I secretion in gram-negative bacteria. Biochim Biophys Acta 1694, 149161.[Medline]
Eswaran, J., Hughes, C. & Koronakis, V. (2003). Locking TolC entrance helices to prevent protein translocation by the bacterial type I export apparatus. J Mol Biol 327, 309315.[CrossRef][Medline]
Federici, L., Du, D., Walas, F., Matsumura, H., Fernandez-Recio, J., McKeegan, K. S., Borges-Walmsley, M. I., Luisi, B. F. & Walmsley, A. R. (2005). The crystal structure of the outer membrane protein VceC from the bacterial pathogen Vibrio cholerae at 1.8 Å resolution. J Biol Chem 280, 1530715314.
Funkhouser, A., Steinhoff, M. C. & Ward, J. (1991). Haemophilus influenzae disease and immunization in developing countries. Rev Infect Dis 13, S542S554.[Medline]
Jellen-Ritter, A. S. & Kern, W. V. (2001). Enhanced expression of the multidrug efflux pumps AcrAB and AcrEF associated with insertion element transposition in Escherichia coli mutants selected with a fluoroquinolone. Antimicrob Agents Chemother 45, 14671472.
Koronakis, V., Sharff, A., Koronakis, E., Luisi, B. & Hughes, C. (2000). Crystal structure of the bacterial membrane protein TolC central to multidrug efflux and protein export. Nature 405, 914919.[CrossRef][Medline]
Koronakis, V., Eswaran, J. & Hughes, C. (2004). Structure and function of TolC: the bacterial exit duct for proteins and drugs. Annu Rev Biochem 73, 467489.[CrossRef][Medline]
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680685.[CrossRef][Medline]
Letoffe, S., Ghigo, J. M. & Wandersman, C. (1994). Secretion of the Serratia marcescens HasA protein by an ABC transporter. J Bacteriol 176, 53725377.
Lomovskaya, O. & Lewis, K. (1992). Emr, an Escherichia coli locus for multidrug resistance. Proc Natl Acad Sci U S A 89, 89388942.
Nikaido, H. (1994). Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264, 382388.
Paulsen, I. T., Nguyen, L., Sliwinski, M. K., Rabus, R. & Saier, M. H., Jr (2000). Microbial genome analyses: comparative transport capabilities in eighteen prokaryotes. J Mol Biol 301, 75100.[CrossRef][Medline]
Poole, K. (2005). Efflux-mediated antimicrobial resistance. J Antimicrob Chemother 56, 2051.
Prilipov, A., Phale, P. S., Van Gelder, P., Rosenbusch, J. P. & Koebnik, R. (1998). Coupling site-directed mutagenesis with high-level expression: large scale production of mutant porins from E. coli. FEMS Microbiol Lett 163, 6572.[CrossRef][Medline]
Sanchez, L., Pan, W., Vinas, M. & Nikaido, H. (1997). The acrAB homolog of Haemophilus influenzae codes for a functional multidrug efflux pump. J Bacteriol 179, 68556857.
Schulein, R., Gentschev, I., Mollenkopf, H. J. & Goebel, W. (1992). A topological model for the haemolysin translocator protein HlyD. Mol Gen Genet 234, 155163.[Medline]
Tikhonova, E. B., Wang, Q. & Zgurskaya, H. I. (2002). Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. J Bacteriol 184, 64996507.
Trepod, C. M. & Mott, J. E. (2004). Identification of the Haemophilus influenzae tolC gene by susceptibility profiles of insertionally inactivated efflux pump mutants. Antimicrob Agents Chemother 48, 14161418.
Turk, D. C. (1984). The pathogenicity of Haemophilus influenzae. J Med Microbiol 18, 116.[Medline]
Wandersman, C. & Delepelaire, P. (1990). TolC, an Escherichia coli outer membrane protein required for hemolysin secretion. Proc Natl Acad Sci U S A 87, 47764780.
Wong, K. K., Brinkman, F. S., Benz, R. S. & Hancock, R. E. (2001). Evaluation of a structural model of Pseudomonas aeruginosa outer membrane protein OprM, an efflux component involved in intrinsic antibiotic resistance. J Bacteriol 183, 367374.
Received 23 December 2005;
revised 1 March 2006;
accepted 6 March 2006.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |